Pacific Center for Financial Services’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.9K Hold
26
﹤0.01% 379
2026
Q1
$4.49K Hold
26
﹤0.01% 394
2025
Q4
$4.07K Hold
26
﹤0.01% 385
2025
Q3
$4.07K Hold
26
﹤0.01% 385
2025
Q2
$3.94K Hold
26
﹤0.01% 378
2025
Q1
$3.91K Hold
26
﹤0.01% 374
2024
Q4
$4.8K Hold
26
﹤0.01% 362
2024
Q3
$5.12K Hold
26
﹤0.01% 356
2024
Q2
$5.37K Hold
26
﹤0.01% 352
2024
Q1
$7.04K Buy
+26
New +$6.21K ﹤0.01% 336

Other funds holding CRL

Pacific Center for Financial Services's CRL Position: Q2 2026 in Review

Pacific Center for Financial Services held its Charles River Laboratories (CRL) position steady in Q2 2026 at 26 shares worth $5.9K. The position accounts for ﹤0.01% of the portfolio, ranked #379.

Pacific Center for Financial Services first reported a position in CRL in Q1 2024 and has held it in 10 quarters since. The position peaked at $7.04K in Q1 2024. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Pacific Center for Financial Services held 26 shares of Charles River Laboratories worth $5.9K as of Q2 2026.
  • Pacific Center for Financial Services left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Pacific Center for Financial Services's portfolio in Q2 2026, its #379 holding.
  • Pacific Center for Financial Services first reported a position in Charles River Laboratories in Q1 2024 and has held it in 10 quarters since.
  • Pacific Center for Financial Services's Charles River Laboratories position peaked at $7.04K in Q1 2024.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Pacific Center for Financial Services's 13F filing for Q2 2026, filed 5 Aug 2026.